Pharmaceuticals
News Releases
2020
November
October
Pharmaceuticals
Quick NaviTM Rapid Diagnostic Test in Japan Now Supports Simultaneous Testing for Influenza and COVID-19 Through Collection of a Single Testing Sample
Nutraceuticals
Debut of InnerSignal Skin Care Brand Outside Japan - Launched in South Korea as Functional Cosmetics with Two Key Benefits -
Pharmaceuticals
Otsuka and its subsidiary Astex announce results of phase 3, ASTRAL-2 and ASTRAL-3 trials of guadecitabine in patients with previously treated AML and MDS/CMML
Pharmaceuticals
Positive Top-Line Results in Phase 3 Trial of OPC-61815, a V2 -Receptor Antagonist for the Treatment of Cardiac Edema
Pharmaceuticals
Quick NaviTM-COVID 19 Ag Rapid Diagnostic Test in Japan Now Enables Test Sample Collection from Front of Nasal Cavity
September
Corporate
Otsuka Group Acquires ISO 14001 Certification -Reinforcement of group-wide environmental initiatives-
Pharmaceuticals
Otsuka Has Filed an Application in Japan for Approval of Difamilast (OPA-15406) as an Atopic Dermatitis Drug
Pharmaceuticals
Otsuka's ABILIFY MAINTENA approved for the additional indication of bipolar I disorder in Japan
Nutraceuticals
- Creating a Society that Supports Ongoing Employee Health - Full-scale launch of "Kenko Shacho" community website connecting corporate leaders
Nutraceuticals
Smart Nutrition for New Lifestyles Announcing SOYJOY Green Tea & Macadamia Moist Texture Highlights the Mellow Astringency and Savor of Green Tea
Nutraceuticals
Otsuka Pharmaceutical Supports High School Students in Summer 2020 Supporting events across Japan that are close to their hearts, including alternative athletic competitions
Pharmaceuticals
Top-line Results from Global Phase 3 Program of Vadadustat, a Drug Candidate for Treatment of Renal Anemia due to Chronic Kidney Disease in Non-Dialysis Patients
August
Pharmaceuticals
Novartis Pharma and Otsuka to Launch Entresto® Tablets in Japan for Patients with Chronic Heart Failure
Pharmaceuticals
Otsuka to Co-market New Diagnostic Test for COVID-19, Quick Navi-COVID 19 Ag-Confirmation of test results in just 15 minutes, and easy-to-read results shown in two contrasting colors-
July
June
Pharmaceuticals
Novartis Pharma obtains manufacturing and marketing approval in Japan for Entresto® tablet as angiotensin receptor neprilysin inhibitor (ARNI) for chronic heart failure
Pharmaceuticals
Samsca®approved in Japan for additional indication of hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Pharmaceuticals
Otsuka Pharmaceutical and Axcelead Drug Discovery Partners announce joint research in CNS indications
Pharmaceuticals
Clinical program for NY-ESO-1/siTCRTM gene therapy candidate receives designation in Japan as Orphan Regenerative Medicine
Pharmaceuticals
Japan's MHLW grants Sakigake Designation to comprehensive genomic profiling assay for hematologic malignancies co-developed by Otsuka
Nutraceuticals
Introduction of Set of Heat Disorder-related Teaching Materials: "Get Back That Sweat! Preventing Heat Disorders Together"
Pharmaceuticals
Launch of a New Combination Ophthalmic Solution for the Treatment of Glaucoma and Ocular Hypertension, AILAMIDE® Combination Ophthalmic Suspension
Pharmaceuticals
Otsuka Announces Positive Top-line Results from Two Phase 3 Studies of Centanafadine for the Treatment of Attention-deficit Hyperactivity Disorder (ADHD) in Adult Patients
May
Pharmaceuticals
Deltyba® (delamanid) approved in Russian Federation for treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB)
Pharmaceuticals
Launch of Aspirin/Vonoprazan Fumarate Combination Tablets: "Cabpirin® Combination Tablets"
Pharmaceuticals
Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
April
Corporate
Otsuka Pharmaceutical to use CO2-free electricity at all plants in Japan (PDF: 96.4 KB)
Nutraceuticals
Research on the Relationship Between Hair Problems and Capacity to Produce Equol
Pharmaceuticals
Otsuka Enters into Licensing Agreement in Japan for Bempedoic Acid, a Treatment for Hypercholesterolemia
Pharmaceuticals
Otsuka to Introduce QuickNaviTM-Adeno2, an Adenovirus Quick Measurement Kit- Faster and clearer test results with two contrasting colors -
March
Pharmaceuticals
Development of the first comprehensive genomic profiling assay for hematologic malignancies in Japan- Consortium of major Japanese hospitals and Otsuka Pharmaceutical start a project to evaluate its clinical utility -
Pharmaceuticals
Otsuka Announces Top-line Results from Two Phase 3 Studies in Japan for Atopic Dermatitis Drug Candidate Difamilast (OPA-15406)
Pharmaceuticals
Otsuka's Busulfex Receives Additional Indication in Japan as a Conditioning regimen Prior to Autologous Hematopoietic Stem Cell Transplantation for Malignant Lymphoma
Pharmaceuticals
Cabpirin® Combination Tablet Receives Regulatory Approval in Japan for Treatment of Acid-related Diseases in Patients Needing Low-dose Aspirin
Nutraceuticals
Dietary Education App "SketchCook" Recognized with Ministry of Education, Culture, Sports, Science and Technology(MEXT) "Award for Companies Promoting Experience-based Learning Activities for Youth 2019"
Nutraceuticals
Newly published findings on inhibitory effect of near-infrared (IRA) radiation on human epidermal cell proliferation and potential mechanisms
Corporate
Otsuka Pharmaceutical Reappointments and New Appointments of Board Members and Statutory Auditors (PDF: 57.4 KB)
Nutraceuticals
Introducing InnerSignal Rejuvenate ONE-All-in-One Skin Care Product with Time-Lapse Penetration Combines Lightening and Three Basic Skin Care Functions-
Pharmaceuticals
Otsuka enters into co-promotion agreement for angiotensin receptor neprilysin inhibitor (ARNI) LCZ696 in Japan
February
Pharmaceuticals
First-of-its-kind global collaboration launched to develop transformative treatment regimens for tuberculosis
Pharmaceuticals
Otsuka Pharmaceutical Establishes Subsidiary in Malaysia
Nutraceuticals
Introducing New UL·OS Face & Body Sheet A single sheet provides convenient facial and body care
Nutraceuticals
Launch of "Health Support Plus" Service to manage workforce health based on desknet's NEO groupware
Nutraceuticals
Whole soy nutrition bar delivers the same satisfying crunchy texture with a significant reduction in sugars SOYJOY Peanuts Renewal Launch
Pharmaceuticals
Otsuka Pharmaceutical and the Japan Kidney Association Form Collaborative Agreement -Aim to identify practical uses of basic research in the kidney field-
Pharmaceuticals
Otsuka announces that subsidiary Astex Pharmaceuticals' NDA for ASTX727 (oral C-DEC), for the treatment of MDS and CMML, has been accepted for priority review by the U.S. FDA
Nutraceuticals
Tokyo Marathon 2020 - Connecting With the World Otsuka Pharmaceutical to be an Official Partner for 14th consecutive year
January
Nutraceuticals
Otsuka Pharmaceutical Establishes Health Beverage Subsidiary in Mexico
Pharmaceuticals
Otsuka announces positive top-line results from clinical trials in Japan offremanezumab as a prophylactic treatment for migraine
Corporate
Otsuka Pharmaceutical Awarded Grand Prize in Tokyo Metropolitan Government Women's Participation Awards for First Year of the Reiwa Era
Pharmaceuticals